-
-
Call more information
660-596-2224 -
Authors: Chia, Pamela A. MD, MS; Wolfe, Michael W. MD Anesthesia & Analgesia 139(2):p 273-277, August 2024. Sugammadex, a modified γ cyclodextrin, was approved by the US Food and Drug Administration (FDA) in 2015 for reversal of steroidal neuromuscular blockade. Used in the perioperative setting for reversal of amino-steroid paralytics, such as rocuronium and vecuronium, […]
Read MoreAUTHORS: Ortner, Clemens M. MS, MD et al Anesthesia & Analgesia 139(2):p 332-338, August 2024. | BACKGROUND: Anesthesiology experts advocate for formal education in maternal critical care, including the use of focused cardiac ultrasound (FCU) in high-acuity obstetric units. While benefits and feasibility of FCU performed by experts have been well documented, little evidence exists on the […]
Read MoreASA Monitor July 2024, Vol. 88, 35. Based on the depth of sedation continuum published by ASA, which of the following patient responses is MOST consistent with moderate sedation? (A) Purposeful response to verbal or tactile stimulation (B) Purposeful response only to repeated or painful stimulation (C) Reflex withdrawal following a painful stimulus ASA developed a […]
Read MoreAUTHORS: Liu, Sunny Yang BA et al Anesthesia & Analgesia 139(2):p 366-374, August 2024. BACKGROUND: Traumatic brain injury (TBI) is an expensive and common public health problem. Management of TBI oftentimes includes sedation to facilitate mechanical ventilation (MV) for airway protection. Dexmedetomidine has emerged as a potential candidate for improved patient outcomes when used for early […]
Read MoreAuthor: J. David Clark, M.D., Ph.D. Anesthesiology August 2024, Vol. 141, 201–203. “[T]his new [capsaicin] prodrug formulation may provide a novel approach to postoperative analgesia resulting from a single local injection that lasts for days.” Image: A. Johnson, Vivo Visuals Studio. Fundamental advancements in our field do not occur every day, so it is particularly exciting […]
Read More